Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Please Wait
Applying Filters...
01 8Jevtana
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 528
2018 Revenue in Millions : 460
Growth (%) : 15
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 648
2019 Revenue in Millions : 585
Growth (%) : 11
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 501
2020 Revenue in Millions : 584
Growth (%) : -15
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 18.20%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 300
2014 Revenue in Millions : 353
Growth (%) : 18%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 379
2015 Revenue in Millions : 340
Growth (%) : 12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 479
2016 Revenue in Millions : 444
Growth (%) : 8
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 477
2017 Revenue in Millions : 436
Growth (%) : 9%
LOOKING FOR A SUPPLIER?